Publications

Detailed Information

The association between prescription drugs and colorectal cancer prognosis: a nationwide cohort study using a medication-wide association study

DC Field Value Language
dc.contributor.authorWoo, Hyeong-Taek-
dc.contributor.authorJeong, Seung-Yong-
dc.contributor.authorShin, Aesun-
dc.date.accessioned2023-08-11T01:44:19Z-
dc.date.available2023-08-11T10:44:51Z-
dc.date.issued2023-07-10-
dc.identifier.citationBMC Cancer, Vol.23(1):643ko_KR
dc.identifier.issn1471-2407-
dc.identifier.urihttps://hdl.handle.net/10371/195347-
dc.description.abstractBackground With the availability of health insurance claim data, pharmacovigilance for various drugs has been
suggested; however, it is necessary to establish an appropriate analysis method. To detect unintended drug effects
and to generate new hypotheses, we conducted a hypothesis-free study to systematically examine the relationship
between all prescription nonanticancer drugs and the mortality of colorectal cancer patients.
Methods We used the Korean National Health Insurance Service-National Sample Cohort database. A total of
2,618 colorectal cancer patients diagnosed between 2004 and 2015 were divided into drug discovery and drug
validation sets (1:1) through random sampling. Drugs were classified using the Anatomical Therapeutic Chemical
(ATC) classification system: 76 drugs classified as ATC level 2 and 332 drugs classified as ATC level 4 were included
in the analysis. We used a Cox proportional hazard model adjusted for sex, age, colorectal cancer treatment, and
comorbidities. The relationship between all prescription nonanticancer drugs and the mortality of colorectal cancer
patients was analyzed, controlling for multiple comparisons with the false discovery rate.
Results We found that one ATC level-2 drug (drugs that act on the nervous system, including
parasympathomimetics, addictive disorder drugs, and antivertigo drugs) showed a protective effect related to
colorectal cancer prognosis. At the ATC level 4 classification, 4 drugs were significant: two had a protective effect
(anticholinesterases and opioid anesthetics), and the other two had a detrimental effect (magnesium compounds
and Pregnen [4] derivatives).
Conclusions In this hypothesis-free study, we identified four drugs linked to colorectal cancer prognosis. The MWAS
method can be useful in real-world data analysis.
Keywords Colorectal cancer, Medication-wide association study, Pharmacovigilance, Hypothesis free, Agnostic,
Korean population
ko_KR
dc.description.sponsorshipThis work was supported by the Bisa Research Grant of Keimyung University in 2022 and the National Research Foundation of Korea (2017R1A2B4009233). The funding organizations had no role in the design or conduct of this research.ko_KR
dc.language.isoenko_KR
dc.publisherBMCko_KR
dc.subjectColorectal cancer-
dc.subjectMedication-wide association study-
dc.subjectPharmacovigilance-
dc.subjectHypothesis free-
dc.subjectAgnostic-
dc.subjectKorean population-
dc.titleThe association between prescription drugs and colorectal cancer prognosis: a nationwide cohort study using a medication-wide association studyko_KR
dc.typeArticleko_KR
dc.identifier.doi10.1186/s12885-023-11105-9ko_KR
dc.citation.journaltitleBMC Cancerko_KR
dc.language.rfc3066en-
dc.rights.holderThe Author(s)-
dc.date.updated2023-07-16T03:11:07Z-
dc.citation.number1ko_KR
dc.citation.volume23ko_KR
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share